Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adverse side effects associated with latanoprost

J A Rowe1, M G Hattenhauer, D C Herman

  • 1Mayo Clinic, Rochester, MN 55905, USA.

American Journal of Ophthalmology
|December 31, 1997
PubMed
Summary

Topical latanoprost, used for glaucoma, can cause serious adverse reactions. These include ocular hypotony, choroidal effusions, macular edema, and facial rash, requiring clinical awareness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No Evidence that Knops Blood Group Polymorphisms Affect Complement Receptor 1 Clustering on Erythrocytes.

Scientific reports·2017
Same author

Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children.

Genes and immunity·2016
Same author

Removal of cadmium, lead, and zinc from soil by a rhamnolipid biosurfactant.

Environmental science & technology·2012
Same author

Strain variation in early innate cytokine induction by Plasmodium falciparum.

Parasite immunology·2010
Same author

Initial results of QuantiFERON-TB Gold testing in patients with uveitis.

Eye (London, England)·2008
Same author

Inter- and intra-specific cuticle variation between amphimictic and parthenogenetic species of root-knot nematode (Meloidogyne spp.) as revealed by a bacterial parasite (Pasteuria penetrans).

International journal for parasitology·2008

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Latanoprost is a prostaglandin analog commonly prescribed for primary open-angle glaucoma.
  • Effective in lowering intraocular pressure, its safety profile requires ongoing evaluation.

Observation:

  • Three patients initiating topical latanoprost treatment presented with distinct adverse reactions.
  • Reactions were observed within 1 to 4 weeks of starting the medication.

Findings:

  • Adverse events included ocular hypotony with choroidal effusions, recurrent cystoid macular edema, and facial rash.
  • These reactions occurred despite latanoprost's intended therapeutic effect on intraocular pressure.

Implications:

  • Clinicians must be vigilant for these potential complications associated with latanoprost therapy.
  • Early recognition and management are crucial for patient safety and visual outcomes.

Related Experiment Videos